Anvisa aprova Sarclisa® para o tratamento de pacientes elegíveis ao transplante com mieloma múltiplo recém diagnosticado

Oncologia Brasil

Oncologia Brasil

1 set, 2025

Hematologia
Oncologia Brasil

Escrito por Oncologia Brasil

Biografia

Oncologia Brasil is a specialized oncology platform with a team of experts covering all aspects of cancer treatment, providing relevant content and personalized solutions. Its goal is to meet the needs of healthcare professionals, pharmaceutical industries, and patients by offering reliable and up-to-date information to improve cancer understanding and management.